Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,299	128 Pages	Prodture	November, 2024	PROD19315081

Best Price Guarantee
Price	from $4,299
Length	128 Pages
Publisher	Prodture
Published Date	November, 2024
SKU	PROD19315081

Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape

The global idiopathic pulmonary fibrosis treatment market is expected to grow at a CAGR of around 8.2% during 2025-2034. This report on global idiopathic pulmonary fibrosis treatment market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global idiopathic pulmonary fibrosis treatment market by segmenting the market based on drug class, end-user, and region. Also, detailed profiles of companies operating in the idiopathic pulmonary fibrosis treatment market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Prevalence of Fibrotic Diseases
• Rising Geriatric Population

Market Challenges

• Lack of Awareness
• Availability of Proper Treatment

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Drug Class

• MAPK Inhibitors
• Tyrosine Inhibitors
• Autotaxin Inhibitors

Market by End User

• Hospitals
• Long-term Care Facilities
• Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

1. Preface: 1.1 Objective; 1.2 Target Audience & Key Offerings; 1.3 Report’s Scope; 1.4 Research Methodology; 1.4.1 Phase I; 1.4.2 Phase II; 1.4.3 Phase III; 1.5 Assumptions
2. Key Insights
3. Global Idiopathic Pulmonary Fibrosis Treatment Market: 3.1. Introduction; 3.2. Market Drives; 3.3. Market Challenges
4. Global Idiopathic Pulmonary Fibrosis Treatment Market Analysis: 4.1. Market Portraiture; 4.2. Market Size; 4.3. Market Forecast; 4.4. Impact of COVID-19
5. Global Idiopathic Pulmonary Fibrosis Treatment Market by Drug Class: 5.1. Introduction; 5.2. MAPK Inhibitors; 5.3. Tyrosine Inhibitors; 5.4. Autotaxin Inhibitors
6. Global Idiopathic Pulmonary Fibrosis Treatment Market by End User: 6.1. Introduction; 6.2. Hospitals; 6.3. Long-term Care Facilities; 6.4. Others
7. Global Idiopathic Pulmonary Fibrosis Treatment Market by Region: 7.1. Introduction; 7.2. Europe; 7.2.1. Germany; 7.2.2. United Kingdom; 7.2.3. France; 7.2.4. Italy; 7.2.5. Spain; 7.2.6. Russia; 7.2.7. Netherlands; 7.2.8. Rest of the Europe; 7.3. North America; 7.3.1. United States; 7.3.2. Canada; 7.4. Asia Pacific; 7.4.1. China; 7.4.2. Japan; 7.4.3. India; 7.4.4. South Korea; 7.4.5. Australia; 7.4.6. Indonesia; 7.4.7. Rest of the Asia Pacific; 7.5. Latin America; 7.5.1. Mexico; 7.5.2. Brazil; 7.5.3. Argentina; 7.5.4. Rest of Latin America; 7.6. Middle East & Africa; 7.6.1. Saudi Arabia; 7.6.2. Turkey; 7.6.3. Iran; 7.6.4. United Arab Emirates; 7.6.5. Rest of Middle East & Africa
8. SWOT Analysis
9. Porter’s Five Forces
10. Market Value Chain Analysis
11. Competitive Landscape: 11.1. Competitive Scenario; 11.2. Company Profiles; 11.2.1. AdAlta Pty Ltd.; 11.2.2. Angion Biomedica Corp.; 11.2.3. Boehringer Ingelheim International GmbH; 11.2.4. Bristol-Myers Squibb Company; 11.2.5. Cipla Inc.; 11.2.6. F. Hoffmann-La Roche AG (Roche Holding AG); 11.2.7. Fibrogen Inc.; 11.2.8. Galapagos NV; 11.2.9. Liminal BioSciences Inc.; 11.2.10. Medicinova Inc.; 11.2.11. Merck & Co. Inc.; 11.2.12. Novartis AG; 11.2.13. Vectura Group Plc.
List of Figures: Figure 1: Global Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 2: Global Idiopathic Pulmonary Fibrosis Treatment Market by Drug Class, 2024; Figure 3: Global Idiopathic Pulmonary Fibrosis Treatment Market by End User, 2024; Figure 4: Global Idiopathic Pulmonary Fibrosis Treatment Market by Region, 2024; Figure 5: Global Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 6: Global Idiopathic Pulmonary Fibrosis Treatment Market by Drug Class (in %), 2024 & 2034; Figure 7: Global MAPK Inhibitors Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 8: Global MAPK Inhibitors Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 9: Global Tyrosine Inhibitors Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 10: Global Tyrosine Inhibitors Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 11: Global Autotaxin Inhibitors Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 12: Global Autotaxin Inhibitors Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 13: Global Idiopathic Pulmonary Fibrosis Treatment Market by End User (in %), 2024 & 2034; Figure 14: Global Hospitals Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 15: Global Hospitals Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 16: Global Long-term Care Facilities Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 17: Global Long-term Care Facilities Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 18: Global Other Facilities Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 19: Global Other Facilities Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 20: Global Idiopathic Pulmonary Fibrosis Treatment Market by Region (in %), 2024 & 2034; Figure 21: Europe Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 22: Europe Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 23: Europe Idiopathic Pulmonary Fibrosis Treatment Market by Country (in %), 2024 & 2034; Figure 24: Germany Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 25: United Kingdom Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 26: France Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 27: Italy Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 28: Spain Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 29: Russia Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 30: Netherlands Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 31: Rest of Europe Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 32: North America Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 33: North America Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 34: North America Idiopathic Pulmonary Fibrosis Treatment Market by Country (in %), 2024 & 2034; Figure 35: United States Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 36: Canada Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 37: Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 38: Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 39: Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Market by Country (in %), 2024 & 2034; Figure 40: China Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 41: Japan Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 42: India Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 43: South Korea Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 44: Australia Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 45: Indonesia Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 46: Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 47: Latin America Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 48: Latin America Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 49: Latin America Idiopathic Pulmonary Fibrosis Treatment Market by Country (in %), 2024 & 2034; Figure 50: Mexico Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 51: Brazil Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 52: Argentina Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 53: Rest of Latin America Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 54: Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2024; Figure 55: Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2025-2034; Figure 56: Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Market by Country (in %), 2024 & 2034; Figure 57: Saudi Arabia Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 58: Turkey Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 59: Iran Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 60: UAE Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 61: Rest of Middle East and Africa Idiopathic Pulmonary Fibrosis Treatment Market (in US$ Million), 2020-2034; Figure 62: Market Value Chain
List of Tables: Table 1: Global Idiopathic Pulmonary Fibrosis Treatment Market Portraiture; Table 2: Global Idiopathic Pulmonary Fibrosis Treatment Market by Drug Class (in US$ Million), 2024 & 2034; Table 3: Global Idiopathic Pulmonary Fibrosis Treatment Market by End User (in US$ Million), 2024 & 2034; Table 4: Global Idiopathic Pulmonary Fibrosis Treatment Market by Region (in US$ Million), 2024 & 2034; Table 5: Europe Idiopathic Pulmonary Fibrosis Treatment Market by Country (in US$ Million), 2024 & 2034; Table 6: North America Idiopathic Pulmonary Fibrosis Treatment Market by Country (in US$ Million), 2024 & 2034; Table 7: Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Market by Country (in US$ Million), 2024 & 2034; Table 8: Latin America Idiopathic Pulmonary Fibrosis Treatment Market by Country (in US$ Million), 2024 & 2034; Table 9: Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Market by Country (in US$ Million), 2024 & 2034; Table 10: List of Key Players